Emerging Infectious Disease ISSN: 1080-6059

Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010

Rebekah H. Borse¹, Sundar S. Shrestha, Anthony E. Fiore, Charisma Y. Atkins, James A. Singleton, Carolyn Furlow, and Martin I. Meltzer

Author affiliations: Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 1

Weekly number of clinical cases of influenza A(H1N1)pdm09 virus infection, the number of vaccine doses administered, and the estimated number of cases averted over time because of the vaccination program. Midranges shown for epidemic curve and clinical cases; ranges provided in Table 3.

Figure 1. . . Weekly number of clinical cases of influenza A(H1N1)pdm09 virus infection, the number of vaccine doses administered, and the estimated number of cases averted over time because of the vaccination program. Midranges shown for epidemic curve and clinical cases; ranges provided in Table 3.

Main Article

¹Current affiliation: Merck & Co., Inc., Lansdale, Pennsylvania, USA.

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.